Simplified immunoradiometric assay for factor VIII coagulant antigen

Area of Science:

• Hematology
• Immunology
• Biochemistry

Background:

• Factor VIII coagulant activity (VIII:C) is critical for hemostasis.
• Quantifying factor VIII coagulant antigen (VIII:CAg) provides insights into hemophilia A.
• Existing methods for VIII:CAg measurement can be complex and time-consuming.

Purpose of the Study:

• To develop a simplified, non-competitive, solid phase immunoradiometric assay for VIII:CAg quantitation.
• To assess the correlation between VIII:CAg levels and VIII:C activity.
• To evaluate the assay's utility in diagnosing and classifying hemophilia A and von Willebrand's disease.

Main Methods:

• Developed a solid phase immunoradiometric assay using immobilized human IgG and rabbit 125I-IgG.
• Utilized both homologous and heterologous antibodies to human factor VIII (FVIII).
• Tested plasma samples from normal donors, von Willebrand's disease patients, and severe hemophilia A patients.

Main Results:

• Demonstrated a strong correlation between VIII:CAg and VIII:C levels in normal plasma (r = 0.84).
• Found undetectable VIII:CAg levels in homozygote von Willebrand's disease patients.
• Enabled classification of severe hemophilia A patients based on measurable or undetectable VIII:CAg levels.

Conclusions:

• The developed assay provides a simplified and efficient method for VIII:CAg quantitation.
• This assay aids in differentiating hemophilia A patient groups and diagnosing von Willebrand's disease.
• Reduced reliance on human antibodies and eliminated immunopurification steps, streamlining the process.